Noveris Health Sciences Inc. is a biotechnology company focused on developing solutions for mental health and vitality enhancement. A key concern is its low current ratio of 0.31, indicating potential liquidity issues. Additionally, the market cap of $3.22M and a significant drop of 15.38% today raise questions about investor confidence. However, a positive ROA of 2.3% suggests some operational efficiency. Overall, while the company has a niche focus, financial stability remains a critical concern.
Loading financial metrics...
Company is burning $357K per quarter with $809K in cash. Approximately 2.3 quarters of runway at current burn rate.
Operating cash flow has been negative for 3 consecutive quarters, burning $1.4M over the last year.
Fortress balance sheet: cash covers total debt 2.2×, providing significant financial flexibility.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q2 (June 30, 2026)